USTR - Statement of Assistant USTR Wendy Culter on the Conclusion of the Second Round of Negotiations of the KORUS FTA
Office of the United States Trade Representative


Statement of Assistant USTR Wendy Culter on the Conclusion of the Second Round of Negotiations of the KORUS FTA

"Thank you. First, I would like to thank the Korean Government and the management and staff of the Shilla Hotel for doing such a wonderful job in hosting me and my delegation this week. 

"I spent all of my time at the hotel this week, but if I had to be stuck in one building for an entire week due to our busy schedule and the weather, I can’t think of a place as nice and friendly at this hotel.

"We wrapped up the second round of the KORUS FTA negotiations today.  This was a busy week, with the teams working around the clock.

"Overall, we made reasonable progress this week.  We continued to develop a better understanding of each other’s position and to bridge differences, and in trade jargon, remove brackets in many of these areas. 

"We agreed on the timeframes for tariff phase-outs for industrial goods, which is a very significant step and we are nearing agreement on the timeframes for tariff phase-outs for agricultural and textiles goods, setting the stage for the exchange of tariff offers by mid-August.

"We also exchanged initial offers in services and investment, and made progress in a number of other negotiating groups.

"FTA negotiations are complex, particularly when you are talking about two large and sophisticated economies like the United States and Korea.  In any FTA, it is customary for the early negotiating rounds to focus on the less complex issues, That is an accurate characterization of our meetings this week.

"Each FTA also has its share of difficult and controversial issues.  The KORUS FTA is no exception.

"On pharmaceuticals, I’m sure you’re aware that thing did not go as planned.  First, let me make clear, the United States position is not to challenge the basic premise of Korea’s national healthcare system nor are we trying to block reform.  That is not our objective.  We recognize Korea faces an aging population and rising health care costs – the United States and other countries around the world faces similar challenges.  What we are saying is any reform should be transparent and fair, and not disproportionately target foreign pharmaceutical products.

"Going into these negotiations, we had agreed to establish a dedicated working group to discuss pharmaceutical trade issues.  To our surprise, upon our arrival in Seoul, we were informed that Korea was going to switch to a positive list system for the reimbursement of pharmaceutical products before we had the opportunity to have meaningful negotiations on these issues. 

"In our view, the decision to proceed with this plan is inconsistent with both the mandate of the Pharmaceutical Working Group and the market-opening spirit of the FTA.  In short, Korea’s decision precluded meaningful negotiations at this time.  Therefore, in order to ensure continued balance in the overall negotiations, we felt that it was appropriate to suspend work in two additional groups: trade remedies and services.

"We believe that this was a balanced and measured response that appropriately reflected our level of concern. 

"Clearly, our preference would have been for all the groups to have met this week as scheduled.  But, under the circumstances, we were left with no choice. 

"That said, while our differences in views in the pharmaceutical sector are challenging and difficult, they are not insurmountable.  Ambassador Kim and I have agreed to continue to work together to get things back on track with respect to pharmaceuticals so as to allow for a productive third round during the week of September 4th. 

"For our part, the United States continues to believe the FTA will generate significant commercial, economic, and strategic benefits for both our countries.

"We remain as convinced as ever that the KORUS FTA is the right path for the United States and Korea, both now and for the coming generations."


click here for printer friendly version

Help Link Site Map Link Contact Us Link
 Search Title Image
Document Library Link
Related Links
Bilateral Trade Agreements
item: Bilateral Agreements
item: Australia FTA
item: Bahrain FTA
item: Chile FTA
item: Colombia FTA
item: Israel FTA
item: Jordan FTA
item: Malaysia FTA
item: Morocco FTA
item: Panama TPA
item: Peru TPA
item: Malaysia FTA
item: Singapore FTA
item: SACU FTA
item: UAE FTA
item: Bilateral Investment Treaties (BITs)
item: Trade and Investment Framework Agreements (TIFAs)